Safety and Efficacy of Drug-Coated Balloons Versus Drug-Eluting Stents in Acute Coronary Syndromes: A Prespecified Analysis of BASKET-SMALL 2.

Publication

Safety and Efficacy of Drug-Coated Balloons Versus Drug-Eluting Stents in Acute Coronary Syndromes: A Prespecified Analysis of BASKET-SMALL 2.

Journal Paper/Review - Jan 10, 2022

Mangner Norman, Farah Ahmed, Ohlow Marc-Alexander, Möbius-Winkler Sven, Weilenmann Daniel, Wöhrle Jochen, Linke Axel, Stachel Georg, Markovic Sinisa, Leibundgut Gregor, Rickenbacher Peter, Cattaneo Marco, Gilgen Nicole, Kaiser Christoph, Scheller Bruno, Jeger Raban V, BASKET-SMALL 2 Investigators

Citation

Mangner N, Farah A, Ohlow M, Möbius-Winkler S, Weilenmann D, Wöhrle J, Linke A, Stachel G, Markovic S, Leibundgut G, Rickenbacher P, Cattaneo M, Gilgen N, Kaiser C, Scheller B, Jeger R, BASKET-SMALL 2 Investigators. Safety and Efficacy of Drug-Coated Balloons Versus Drug-Eluting Stents in Acute Coronary Syndromes: A Prespecified Analysis of BASKET-SMALL 2. Circ Cardiovasc Interv 2022; 15:e011325.

Type

Journal Paper/Review (English)

Journal

Circ Cardiovasc Interv 2022; 15

Publication Date

Jan 10, 2022

Issn Electronic

1941-7632

Pages

e011325

Brief description/objective

Drug-coated balloons (DCBs) are an established treatment strategy for coronary artery disease. Randomized data on the application of DCBs in patients with an acute coronary syndrome (ACS) are limited. We evaluated the impact of clinical presentation (ACS versus chronic coronary syndrome) on clinical outcomes in patients undergoing DCB or drug-eluting stent (DES) treatment in a prespecified analysis of the BASKET-SMALL 2 trial (Basel Kosten Effektivitäts Trial-Drug-Coated Balloons Versus Drug-Eluting Stents in Small Vessel Interventions).